X-linked hypophosphatemia (XLH)
- Development of an FDA dossier in X-Linked Hypophosphatemia (XLH)
- Validation activities of an FDA dossier in XLH
- Psychometric validation of the Brief Pain Inventory (BPI) and Western Ontario and McMaster osteoarthritis index (WOMAC) in XLH using online survey data
- Exploration of content validity of PROMIS items for use in children with XLH
- Psychometric evaluation of the BPI-SF and WOMAC in XLH using phase III trial data